Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-24-017177

Options or other derivatives

  • SR. VP & CCO acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wright Richard M. SR. VP & CCO 2024-06-13 Grant or award · Incentive Stock Option (right to buy) +65,000 65,000 D
Loading xslF345X05/form4-06172024_080608.xml…